Genus Company News

Epic Code:
Sub Sector:
Market Cap:

Pharmaceuticals & Biotechnology
UK Main Market
346.9365534 GBPm

Data as of 10:00 23/09/2009. Check director details and other company announcments at Genus Website .

RNS News for Genus

Regulatory News Service : RNS provides a service that enables local or international listed companies to meet company news reporting obligations in UK, Europe and US - international filings use different processes: Provides investors & professionals equal access to new company information as it is released. For further details of RNS news see London Stock Exchange website.

Latest Genus News

Liberum Capital Reaffirms “Buy” Rating for Genus plc (LON:GNS)
BBNS - 8 hours ago
Genus plc logo Genus plc (LON:GNS)'s stock had its “buy” rating restated by equities researchers at Liberum Capital in a research report issued on Monday, July 3rd.

07/22/2017 10:56 PM

Genus plc's (LON:GNS) “Buy” Rating Reiterated at Liberum Capital
The Cerbat Gem - 20 hours ago
Genus plc logo Genus plc (LON:GNS)'s stock had its “buy” rating reiterated by equities research analysts at Liberum Capital in a report issued on Monday, July 3rd.

07/22/2017 11:07 AM

Genus plc's (LON:GNS) “Buy” Rating Reaffirmed at Liberum Capital
Sports Perspectives - Jul 12, 2017
Genus plc logo Genus plc (LON:GNS)'s stock had its “buy” rating restated by stock analysts at Liberum Capital in a note issued to investors on Monday, June 19th.
Genus plc (LON:GNS) Receives Buy Rating from Liberum Capital - Markets Daily
Liberum Capital Reiterates Buy Rating for Genus plc (LON:GNS) - The Cerbat Gem

07/12/2017 01:56 AM

Why I'd buy Tristel plc and avoid Genus plc after HY results
Motley Fool UK - Feb 23, 2017
The market likes FTSE AIM company Tristel's (LSE: TSTL) half-year report today. The shares are up more than 8% as I write, so the UK-based manufacturer of infection prevention and contamination control products must be doing something right.

02/23/2017 03:22 PM

Why I'd buy this small-cap over Genus plc despite today's positive results
Motley Fool UK - Nov 17, 2016
Leading animal genetics company Genus (LSE: GNS) has released a positive trading update today. In spite of mixed market conditions, Genus made progress towards its strategic objectives and is performing in line with expectations for the full year ...

11/17/2016 01:30 PM

Genus ordered to pay US$2mln after cow semen court case
Proactive Investors UK - Aug 15, 2016
Animal genetics group Genus plc (LON:GNS) has been ordered by the court to pay at least US$2mln to Sexing Technologies following a court case over its sexed bovine semen processing technology.

08/15/2016 08:20 AM